Guidelines for Scientific Exercise Therapy for People with Spinal Cord Injury

Effectiveness of exercise therapy for people with spinal cord injury using scientific exercise guidelines - Preliminary randomised controlled trial.

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1050220138

Enrollment

Registered

2022-12-23

Start date

2022-12-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

spinal cord injury biplegea

Interventions

Exercise at home for 12 weeks Aerobic exercise and strength training at least twice a week Aerocic exercise At leaset 20 minutes per session, moderate to intense intensity Strength exercise 3 sets

Cardiopulmonary and muscle strengthening training

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Adults with spinal cord injury in the chronic phase (at least one year after onset, neurological injury level C3 or less) due to traumatic or non-traumatic causes, including quadriplegia and paraplegia (as indicated in the guidelines) Adults with spinal cord injury who are outpatients, living at home and have no exercise routine (to test effectiveness and feasibility).

Exclusion criteria

Exclusion criteria: ... persons with cervical spinal cord injury (with upper limb paralysis and difficulty performing voluntary exercise therapy in Japan). Spinal cord injury victims less than 12 months after the onset of the injury. ... older people aged 65 and over. Persons with comorbidities such as cognitive impairment and mental disorders People with chronic diseases for whom it is not appropriate to exercise (e.g. patients with severe blood pressure fluctuations). ... patients with inadequate measurement of maximal oxygen uptake (in the endpoints). (Guidelines may be appropriate for people with spinal cord injury less than 12 months after onset, older than 65 years, or with comorbidities, but there is currently insufficient scientific evidence to draw firm conclusions about the risks and benefits of the guidelines for these individuals.)

Design outcomes

Primary

Measure	Time frame
Maximal oxygen uptake and upper limb muscle strength (grip strength)	—

Secondary

Measure	Time frame
Body composition (muscle and fat mass), blood biochemistry test results (blood sugar, lipids, liver and kidney function), activity level	—

Countries

indonesia, Japan, Thailand

Contacts

Public ContactJung Kyungsu

wakayma medical university

kyungsuj@wakayama-med.ac.jp+81-73-488-1932

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026